Pharmacologic manipulation of ob expression in a dietary model of obesity.
about
Lorcaserin: drug profile and illustrative model of the regulatory challenges of weight-loss drug developmentAdrenalectomy stimulates hypothalamic proopiomelanocortin expression but does not correct diet-induced obesityDirect binding of activated c-Src to the beta 3-adrenergic receptor is required for MAP kinase activation.CCAAT/enhancer-binding protein alpha is required for transcription of the beta 3-adrenergic receptor gene during adipogenesis.Leptin and its potential role in human obesity.ApoA-IV: current and emerging roles in intestinal lipid metabolism, glucose homeostasis, and satietyAromatase-deficient (ArKO) mice have a phenotype of increased adiposity.Apolipoprotein A-IV: a protein intimately involved in metabolism.Leptin treatment increases suppressors of cytokine signaling in central and peripheral tissues.Regulatory effects of resveratrol on glucose metabolism and T-lymphocyte subsets in the development of high-fat diet-induced obesity in C57BL/6 mice.Effect of leptin on intestinal apolipoprotein AIV in response to lipid feeding.Peripheral injection of risperidone, an atypical antipsychotic, alters the bodyweight gain of rats.Sympathetic inhibition, leptin, and uncoupling protein subtype expression in normal fasting rats.POMC neurons expressing leptin receptors coordinate metabolic responses to fasting via suppression of leptin levels.Isoproterenol decreases leptin expression in adipose tissue of obese humans.beta 3-Adrenergic-mediated suppression of leptin gene expression in rats.Mutation of the RIIbeta subunit of protein kinase A differentially affects lipolysis but not gene induction in white adipose tissue.
P2860
Q22241480-D6600976-DC61-4E8E-BA77-EA7AB20A97EEQ24805593-ED7EAB07-03EB-41CC-A327-4806EBB190CCQ30168727-2B391B71-3E9E-458D-9676-0ED4CD88BDAAQ31452122-9D579A95-ED14-48F5-A441-946F1306487AQ33680494-EECEFFB4-7BD1-469B-861B-7F837DC66550Q35178645-6302F21C-7BDC-4669-B684-1EAACD05F649Q35823766-979CEA7E-C962-4BB4-945C-D157258B9F96Q35886250-803A7F43-1E97-488E-A056-C140C1F1B840Q38322266-FB4E7136-643C-411F-9977-ACF01B51D31EQ42705723-271EB08A-855A-4486-B212-60EBF2AB3470Q43708462-44FB061D-56CD-4FB6-8B27-7E1A7D2C0A8DQ44169297-EB9D7E53-4A5E-4795-8750-3D7B49C922A9Q50142667-51C7F383-5B88-4B4B-9A0D-F347F15611ABQ50419868-183C489B-466C-435D-A678-868D39B2F657Q51563149-2E2F79A1-4C9A-4DD9-B667-CE9EEB409C0DQ51575019-3BC0A946-D0E1-4BA4-A4E7-94ABA8FB0497Q52537289-E429E40F-D7C6-49E8-9950-072ABE56873D
P2860
Pharmacologic manipulation of ob expression in a dietary model of obesity.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Pharmacologic manipulation of ob expression in a dietary model of obesity.
@en
type
label
Pharmacologic manipulation of ob expression in a dietary model of obesity.
@en
prefLabel
Pharmacologic manipulation of ob expression in a dietary model of obesity.
@en
P2860
P356
P1476
Pharmacologic manipulation of ob expression in a dietary model of obesity.
@en
P2093
P2860
P304
P356
10.1074/JBC.271.16.9437
P407
P577
1996-04-01T00:00:00Z